SCHEMBL10066834

SCHEMBL10066834

BCC(=O)c1ccc(SC)c(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.40
MAPT P10636 4/20 0.38
GAA P10253 2/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
HPGD P15428 4/20 0.37
ALDH1A1 P00352 3/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 4/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPC1 O15118 2/20 0.35
PIM1 P11309 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
STK17B O94768 1/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28278468 0.86 MAPT (0.51) ARMAPTGAAHPGDALDH1A1
SCHEMBL6113125 0.85 PTPN1 (0.50) ARMAPTHPGDALDH1A1TSHR
SCHEMBL29966893 0.85 PTPN1 (0.50) ARMAPTHPGDALDH1A1TSHR
SCHEMBL6112852 0.84 AR (0.43) ARMAPTCES2CES1HPGD
SCHEMBL6519545 0.82 HPGD (0.50) ARMAPTGAAHPGDALDH1A1
SCHEMBL17290737 0.81 MEN1 (0.48) ARMAPTHPGDALDH1A1TSHR
SCHEMBL8402587 0.80 LMNA (0.53) ARMAPTGAACES2CES1
SCHEMBL6721408 0.80 MAPT (0.47) MAPTGAAALDH1A1RAB9ASMN1; SMN2
SCHEMBL6721992 0.80 PLOD2 (0.55) ARMAPTHPGDALDH1A1TSHR
SCHEMBL7988063 0.80 CES2 (0.59) MAPTGAACES2CES1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2468737-A1 SULFONE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2012-06-27 EP disclosed
WO-2011016470-A1 SULFONE DERIVATIVE 第一三共株式会社 (JP) 2011-02-10 WO disclosed